172 related articles for article (PubMed ID: 35758433)
1. Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort.
Bolm L; Nebbia M; Wei AC; Zureikat AH; Fernández-Del Castillo C; Zheng J; Pulvirenti A; Javed AA; Sekigami Y; Petruch N; Qadan M; Lillemoe KD; He J; Ferrone CR;
Ann Surg; 2022 Sep; 276(3):522-531. PubMed ID: 35758433
[TBL] [Abstract][Full Text] [Related]
2. Minimally Invasive vs Open Pancreatectomy for Pancreatic Neuroendocrine Tumors: Multi-Institutional 10-Year Experience of 1,023 Patients.
Zheng J; Pulvirenti A; Javed AA; Michelakos T; Paniccia A; Lee KK; Ferrone CR; Wei AC; He J; Zureikat AH;
J Am Coll Surg; 2022 Aug; 235(2):315-330. PubMed ID: 35839409
[TBL] [Abstract][Full Text] [Related]
3. One hundred thirty resections for pancreatic neuroendocrine tumor: evaluating the impact of minimally invasive and parenchyma-sparing techniques.
DiNorcia J; Lee MK; Reavey PL; Genkinger JM; Lee JA; Schrope BA; Chabot JA; Allendorf JD
J Gastrointest Surg; 2010 Oct; 14(10):1536-46. PubMed ID: 20824378
[TBL] [Abstract][Full Text] [Related]
4. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).
Hashim YM; Trinkaus KM; Linehan DC; Strasberg SS; Fields RC; Cao D; Hawkins WG
Ann Surg; 2014 Feb; 259(2):197-203. PubMed ID: 24253141
[TBL] [Abstract][Full Text] [Related]
5. The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.
Ha S; Song KB; Hong S; Shin D; Park Y; Kwon J; Lee W; Jun E; Lee JH; Hwang DW; Kim SC
ANZ J Surg; 2021 Jul; 91(7-8):E484-E492. PubMed ID: 34291544
[TBL] [Abstract][Full Text] [Related]
6. What Is the Role of Lymph Node Resections in Small Islet Tumors?
Gangi A; Ferrone CR
Adv Surg; 2023 Sep; 57(1):47-58. PubMed ID: 37536861
[TBL] [Abstract][Full Text] [Related]
7. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management.
Lopez-Aguiar AG; Ethun CG; Zaidi MY; Rocha FG; Poultsides GA; Dillhoff M; Fields RC; Idrees K; Cho CS; Abbott DE; Cardona K; Maithel SK
Surgery; 2019 Jul; 166(1):15-21. PubMed ID: 31072670
[TBL] [Abstract][Full Text] [Related]
8. Parenchyma-sparing resections for pancreatic neuroendocrine tumors.
Cherif R; Gaujoux S; Couvelard A; Dokmak S; Vuillerme MP; Ruszniewski P; Belghiti J; Sauvanet A
J Gastrointest Surg; 2012 Nov; 16(11):2045-55. PubMed ID: 22911124
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study Group.
Sahara K; Tsilimigras DI; Moro A; Mehta R; Dillhoff M; Heidsma CM; Lopez-Aguiar AG; Maithel SK; Rocha FG; Kanji Z; Abbott DE; Fisher A; Fields RC; Krasnick BA; Idrees K; Smith PM; Poultsides GA; Makris E; Cho CS; Beems M; Endo I; Pawlik TM
Neuroendocrinology; 2021; 111(1-2):129-138. PubMed ID: 32040951
[TBL] [Abstract][Full Text] [Related]
10. Overestimated Oncologic Significance of Lymph Node Metastasis in G1 Nonfunctioning Neuroendocrine Tumor in the Left Side of the Pancreas.
Yoo YJ; Yang SJ; Hwang HK; Kang CM; Kim H; Lee WJ
Medicine (Baltimore); 2015 Sep; 94(36):e1404. PubMed ID: 26356692
[TBL] [Abstract][Full Text] [Related]
11. Regional Metastatic Behavior of Nonfunctional Pancreatic Neuroendocrine Tumors: Impact of Lymph Node Positivity on Survival.
Jutric Z; Grendar J; Hoen HM; Cho SW; Cassera MA; Newell PH; Hammill CW; Hansen PD; Wolf RF
Pancreas; 2017 Aug; 46(7):898-903. PubMed ID: 28697130
[TBL] [Abstract][Full Text] [Related]
12. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
13. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
Kazanjian KK; Reber HA; Hines OJ
Arch Surg; 2006 Aug; 141(8):765-9; discussion 769-70. PubMed ID: 16924083
[TBL] [Abstract][Full Text] [Related]
14. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.
Parekh JR; Wang SC; Bergsland EK; Venook AP; Warren RS; Kim GE; Nakakura EK
Pancreas; 2012 Aug; 41(6):840-4. PubMed ID: 22781907
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical outcomes between enucleation and regular pancreatectomy in patients with non-functional pancreatic neuroendocrine tumors: a retrospective multicenter and propensity score-matched study.
Yang Z; Gao H; Lu J; Niu Z; Zhu H; Zong Y; Song X; Yang F; Zhou X
Jpn J Clin Oncol; 2021 Apr; 51(4):595-603. PubMed ID: 33395471
[TBL] [Abstract][Full Text] [Related]
16. Sporadic nonfunctional pancreatic neuroendocrine tumors: Risk of lymph node metastases and aggressiveness according to tumor size: A multicenter international study.
Perinel J; Nappo G; Zerbi A; Heidsma CM; Nieveen van Dijkum EJM; Han HS; Yoon YS; Satoi S; Demir IE; Friess H; Vashist Y; Izbicki J; Muller AC; Gloor B; Sandini M; Gianotti L; Subtil F; Adham M
Surgery; 2022 Sep; 172(3):975-981. PubMed ID: 35623953
[TBL] [Abstract][Full Text] [Related]
17. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.
Gratian L; Pura J; Dinan M; Roman S; Reed S; Sosa JA
Ann Surg Oncol; 2014 Oct; 21(11):3515-21. PubMed ID: 24841347
[TBL] [Abstract][Full Text] [Related]
18. LDP vs ODP for pancreatic adenocarcinoma: a case matched study from a single-institution.
Zhang M; Fang R; Mou Y; Chen R; Xu X; Zhang R; Yan J; Jin W; Ajoodhea H
BMC Gastroenterol; 2015 Dec; 15():182. PubMed ID: 26695506
[TBL] [Abstract][Full Text] [Related]
19. Short- and long-term outcomes of laparoscopic organ-sparing resection in pancreatic neuroendocrine tumors: a single-center experience.
Cienfuegos JA; Salguero J; Núñez-Córdoba JM; Ruiz-Canela M; Benito A; Ocaña S; Zozaya G; Martí-Cruchaga P; Pardo F; Hernández-Lizoáin JL; Rotellar F
Surg Endosc; 2017 Oct; 31(10):3847-3857. PubMed ID: 28127714
[TBL] [Abstract][Full Text] [Related]
20. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.
Sohn TA; Yeo CJ; Cameron JL; Koniaris L; Kaushal S; Abrams RA; Sauter PK; Coleman J; Hruban RH; Lillemoe KD
J Gastrointest Surg; 2000; 4(6):567-79. PubMed ID: 11307091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]